The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cellsAlejandro Vázquez‐Martín, Javier A. Menéndez|Cell Cycle|2009Cited by 251
Autophagy Facilitates the Development of Breast Cancer Resistance to the Anti-HER2 Monoclonal Antibody TrastuzumabAlejandro Vázquez‐Martín, Javier A. Menéndez|PLoS ONE|2009Cited by 245
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cellsJavier A. Menéndez, Antonio Segura‐Carretero, Rámón Colomer et al.|BMC Cancer|2007Cited by 191
IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutationsAlejandro Vázquez‐Martín, Javier A. Menéndez|Scientific Reports|2013Cited by 94